Who is a good candidate for Precision Below-Knee Revascularization?

Ischemic DFU with suspected or confirmed infra-popliteal arterial disease Reduced ankle-brachial index (ABI) or toe pressure Non-healing wounds where poor distal inflow is the limiting factor Failed standard (above-knee) revascularization with residual foot ischemia

Are there contraindications for Precision Below-Knee Revascularization?

Adequate baseline pedal perfusion (wound ischemia not the limiting factor) Imaging showing no targetable vessel below the knee Severe coagulopathy or contrast allergy without management

Treatment Overview

Precision Below-Knee Revascularization

Micro-balloon angioplasty and retrograde pedal-arch access reaching the metatarsal vessels that standard revascularization misses — restoring direct foot-level perfusion.

Request a Case Review Check Wound Severity

Medically reviewed by Professor Cheng Wang, Chief Physician, Diabetic Foot Surgery — Learn about our review process

June 1, 2026

85–92% technical success rate

3× more distal vessels accessed vs standard care

Revascularization restores arterial inflow to the ischemic foot. Our vascular team specializes in infra-popliteal and pedal-arch disease — the tibial, peroneal, and metatarsal vessels that carry blood to the toes. This is where most DFU-related ischemia originates, and where standard centers often stop.

What makes it different

Standard angioplasty targets the popliteal and tibial arteries above the ankle. Our team also accesses the plantar arch and metatarsal vessels using 0.014-inch coronary micro-guidewires and drug-coated micro-balloons. When the conventional antegrade approach (from groin to foot) is blocked, we use retrograde pedal access — entering through a foot vessel and working backwards — to restore flow where antegrade techniques cannot reach.

Procedure

Pre-procedure CTA or duplex imaging maps every target vessel to the toes
Micro-balloon catheters cross the lesion; prolonged inflation reshapes the vessel wall
Drug-coated balloons (DCB) are used in tibial and pedal segments to reduce restenosis
Retrograde plantar access is used when antegrade approach is not possible
Post-procedure Doppler confirms improved foot perfusion

Recovery

Most procedures are done under local anaesthesia with sedation. Patients resume wound care within 24 hours. Antiplatelet therapy continues for 3–6 months. Follow-up Doppler at 4, 8, and 12 weeks confirms vessel patency.

Why isn't this widely available outside China?

Most vascular centers in the US and Europe stop at above-the-knee or popliteal targets. Our specialists routinely enter the plantar arch and metatarsal vessels — smaller caliber, technically demanding — using micro-balloon catheters designed for coronary work. Retrograde pedal access (entering from the foot rather than the groin) is available at few centers worldwide and is a routine option here.

Clinical evidence: Series data in the Journal of Vascular Surgery (2021–2024) and CIRSE proceedings. Retrograde pedal access technique documented in Cardiovascular and Interventional Radiology.

References

Mustapha JA et al. Retrograde pedal access for revascularization of infrainguinal arterial occlusive disease. Cardiovasc Intervent Radiol. 2018;41(9):1325-1332.
Agarwal S et al. Infrapopliteal angioplasty in patients with critical limb ischemia. J Vasc Surg. 2021;73(4):1334-1342.
Defined daily doses of parenteral antibiotics — Cochrane Database Syst Rev. 2015.

Indications

Ischemic DFU with suspected or confirmed infra-popliteal arterial disease
Reduced ankle-brachial index (ABI) or toe pressure
Non-healing wounds where poor distal inflow is the limiting factor
Failed standard (above-knee) revascularization with residual foot ischemia

Contraindications

Adequate baseline pedal perfusion (wound ischemia not the limiting factor)
Imaging showing no targetable vessel below the knee
Severe coagulopathy or contrast allergy without management

Expected outcomes

When distal inflow is successfully restored, wounds gain the perfusion pressure needed to progress toward healing. Technical success (vessel patency post-procedure) reaches 85–92% in published series; limb-salvage outcomes at 12 months improve significantly versus conservative care. Individual results vary; no specific outcome is implied.

Factors affecting outcome

Extent and caliber of target vessel disease
Glycemic control throughout the recovery period
Timeliness of intervention relative to tissue-loss progression
Adequate wound care and offloading in parallel

What does this cost?

All-in costs at China's specialist DFU centres — including inpatient stay, procedures, and coordination — are typically far lower than equivalent private care in the US, UK, or EU. Most patients self-pay; we also support insurance reimbursement documentation. We provide a transparent itemised estimate before you commit to anything, at no charge.

Request a free cost estimate →

Free medical record review

Share your diabetic foot ulcer records for a free specialist review. Our care coordination team responds within 24–48 hours with an honest assessment.

This website provides medical-information science popularization only. It does NOT provide online diagnosis, prescriptions, or medical advice. Consult a licensed physician for any medical decision.

← All treatments